Exchange: NASDAQ·Updated 09:23 PM EDT
TXG logo

TXG 10x Genomics Inc - Ordinary Shares - Class A

$75.00
$5.46
(6.77%)
Today
Closed $75.19
$0.19
(0.25%)
Overnight
EarningsNov 5
Mkt Cap$10.51B
Vol4.08M

About TXG

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
32

Bearish Sentiment

How do you feel about TXG?

PensionPulse
$TXG Druckenmiller made a killing off this stock. I'm keeping an eye on it for a reversal but definitely not rushing in, going to nibble when it goes green...
1
1
oz101
$TXG just sold. Good luck to everyone. I bought a measly amount last year at lows of $9 and never expected this run. I will buy maybe next year or two - een at these prices but atm I think this is unsustainable.
4
WOLFSTREET
$TXG 500% UP YTD, 1 F'ING Year, and C² got me (and you) here at about $10 so our gains are probably HIGHER!. The MAGIC of C² is something everyone talks about but does not tell you how to do: #1 PICK GREAT STOCKS #2 LET YOR WINNERS RUN C² answers both questions over and over and over and over and over and over and over and over and over and over and...
1
1
Dr_Stoxx
$TXG and genome plays: they all priced in the bubonic plague...and today whacked as it turns out to have been fake news. $ARKG $XBI $IBB
3
WAJeff
$TXG Huge missed opportunity given how early I was here. Vastly underestimated how far it could travel.
3
yesitrade
$TXG Sooo fortunate today. Predetermined sell order got filled pre-market (for my whopping 83 shares) @ 98.64. Wow. (I have a habit of trying to catch the proverbial "falling knife", so I'm going to let this play out for a couple days and see how it goes...)
2
Guadangia
$TXG I suffered from vertigo so sold my last TXG 20% block past Friday, so 100% out with 5-20% exits at 58, 67, 72, 82 and 94. My media was $13 so this is been one of my best 2026 trades. Good luck if you are still inside, now I will wait for a correction (in case it happens), but wouldn't be surprised if it goes straight to 105 or $125 before taking a deep break.
2
healthcareguru
$TXG this is going to end in tears…there’s a reason every single insider is dumping stock reentless. INSANELY OVERVALUED bs reality. Would be a buyer <$50. 👎🐺 $XBI $XLV $IWM
2
SlatsMcSlappy
$TXG There's got to be something lucrative in the works. It wouldn't be mooning like this for no reason
2
WOLFSTREET
$TXG UP 566% in just 14 MONTHS!!!!!!!!!!!!!! C² does not try to meet or beat the S&P, that is for the average "schmo". C² was built to take my portfolios to the MAX. It does, so I chose to share it. ENJOY! I told you the 10X name here was a sign from the stock gods when this was just 12 dollars, and I posted plenty about it. That screenshot is super old CC 9.0/9.1 ; 9.9 Out Oct 1st for me to share with U! Never the less, C² was kicking serious ass. Plenty more where this came from using the C² alphabet technology. (LOL)
2
CloudCapital
$TXG $80.66 | Strong Uptrend RSI 52.9 (Neutral) MACD Bullish | Vol 2.6x MA20 $80.39 | MA50 $66.53 MA200 $35.48 S $41.93 | R $102.81 Cap $10.51B P/E N/A | Fwd 1052.0 Moderate Outlook | $83.56 (+3.6%)
1
Afisyanadoh
$TXG sorry all. I bought 300 shares at 95$ yesterday. Totally my fault this has gone for shit today. Never fails. Fuk me gently with a sharp stick!
1
ccnau
$TXG From the summary of the last earnings report, see especially bullet point 2. Like Arnold, I'll be back!
1
WOLFSTREET
$TXG Well, official C² 9.9 is out and working very nicely! As part of 9.9, the last BETA feature is now proven and embedded throughout the platform, while a new "AI" feature is introduced. This one just made it under the wire and will be tested until C² X comes out Jan 1 2027. C² X is already road-mapped and will be ready for 2027 new year. So AI is not only accelerating the C² development cycles, but what happens when we point AI to the C² DATA Repository? The answer is what I discovered and was able to get into release 9.9. It effectively reduces the C² data package eval time from 60 seconds to under 5 seconds! After using it for a few weeks, I can tell you it is way faster and better than I. The new C² AI Jedi Master is not yet contributing to the LISTING agent, that is part of C² X road map once AI Jedi completes full testing.
1
yesitrade
$TXG Potentially peaking here? Maybe short for a day-trade. We'll see tomorrow. (I am out)
1
Yooman
$TXG I'm really starting to get scared. The price movement is crazy—I'm up several hundred percent—and, to be honest, I don't know what to do. But I haven't paid attention to Twist in a long time, and I have no idea what the current situation is. I bought it at 17 at some point and just haven't looked at it since. What do you think? What price targets would be realistically achievable?
1
alphapulse_
$TXG levels today 80 is the whole line. tagged 79.94 yesterday — the 52wk high — couldn't hold. reclaim it with volume and 82 opens fast. below: 75 first, then 74 where the breakout started. lose 74 and the move was fake. PM 78.3, knocking on the door.
1
topstockalerts
10x Genomics shares fell sharply, extending recent volatility as investors reassessed the stock’s elevated valuation following a major rally in life sciences tools. The decline came despite Canaccord Genuity raising its price target to $100 from $60 and maintaining a Buy rating, suggesting profit-taking near the $79.18 opening price. The stock has recently suffered declines of 13.4% on Oct. 6 and 6.2% on Oct. 8, after approaching its 52-week high of $102.81. Analyst sentiment remains cautious, with a consensus Hold rating, 11 of 18 analysts recommending Hold or Sell, and an average 12-month price target of $58.60. InvestingPro estimates fair value at $45.08, highlighting the valuation gap. Executives reportedly sold approximately $11.8 billion in shares last quarter without any recorded purchases, while the company remains unprofitable, with analysts forecasting an annual loss of $0.75 per share. $TXG
kevie6537
$TXG nothing but downside for awhile on these. All had massive runnups now it’s profit taking time….wait for bottom and consolidation. $TWST $TEM
bidenomics_man
$TXG thought shit was sweet and would just go up forever huh? Get fucked, welcome to the real world

Advertisement|Remove ads.